Sinclair Pharma Plc (SPH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sinclair Pharma Plc (SPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7466
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It offers complementary aesthetics technologies; and longer duration, natural looking and minimally-invasive treatments. It also offers dermal fillers for folds and lines. Some of Sinclair’s major products include Silhouette Soft; Ellanse; Perfectha and Sculptra. It has direct sales and marketing presence in five major European countries and Brazil. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc (SPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sinclair Pharma Plc, Medical Equipment, Deal Details 10
Asset Purchase 10
Sinclair Pharma to Acquire Worldwide Rights of Refine Support System from Refine for USD11.3 Million 10
Sinclair IS Pharma Acquires Atlean From Stiefel Labs 11
Private Equity 12
Huadong Medicine to Acquire Sinclair Pharma 12
Partnerships 14
Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 14
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 15
Equity Offering 16
Sinclair IS Pharma Announces Private Placement Of Shares For US$33.4 Million 16
Sinclair IS Pharma Announces Private Placement Of Shares For US$15 Million 17
Acquisition 18
Sinclair IS Pharma To Acquire Silhouette Medical For US$117 Million 18
Sinclair IS Pharma Acquires AQTIS Medical 19
Sinclair Pharma Plc – Key Competitors 20
Sinclair Pharma Plc – Key Employees 21
Sinclair Pharma Plc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Financial Announcements 24
Sep 27, 2018: Sinclair Pharma: Interim results for the six months ended 30 June 2018 24
Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 28
Sep 19, 2017: Sinclair Pharma: Interim Results 31
Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016 36
Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update 37
Corporate Communications 38
Apr 30, 2018: Sinclair secures €23 million debt facility 38
Legal and Regulatory 39
Mar 30, 2017: Sinclair Pharma: Additional listing 39
Product News 40
Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil 40
Other Significant Developments 41
Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018 41
Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Sinclair Pharma Plc, Medical Equipment, Key Facts, 2017 2
Sinclair Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Deals By Market, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sinclair Pharma to Acquire Worldwide Rights of Refine Support System from Refine for USD11.3 Million 10
Sinclair IS Pharma Acquires Atlean From Stiefel Labs 11
Huadong Medicine to Acquire Sinclair Pharma 12
Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 14
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 15
Sinclair IS Pharma Announces Private Placement Of Shares For US$33.4 Million 16
Sinclair IS Pharma Announces Private Placement Of Shares For US$15 Million 17
Sinclair IS Pharma To Acquire Silhouette Medical For US$117 Million 18
Sinclair IS Pharma Acquires AQTIS Medical 19
Sinclair Pharma Plc, Key Competitors 20
Sinclair Pharma Plc, Key Employees 21
Sinclair Pharma Plc, Other Locations 22
Sinclair Pharma Plc, Subsidiaries 22

List of Figures
Sinclair Pharma Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sinclair Pharma Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sinclair Pharma Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sinclair Pharma Plc (SPH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Finning International Inc (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays …
  • Noble Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers vaccines, drugs, and medical device development services. The company provides preclinical services such as disease and animal models, drug pharmacology and exploratory toxicology, analytical and la …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Care UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Care UK Ltd (Care UK) is a healthcare service provider that offers clinical and social care services. The company’s healthcare services include treatment centres, General Practitioner(GP) practices, NHS walk-in centres, GP out-of-hours, prison health services, clinical assessment, diagnostic …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MOL Hungarian Oil and Gas PLC (MOL):石油・ガス:M&Aディール及び事業提携情報
    Summary MOL Hungarian Oil and Gas PLC (MOL) is an integrated oil and gas company. It explores for, develops and produces crude oil, natural gas and other gas products. The company refines, transports and stores crude oil; markets crude oil products on wholesale and retail basis, and produces and sel …
  • Aalberts Industries NV:企業のM&A・事業提携・投資動向
    Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • BL&H Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • Oncolytics Biotech Inc (ONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • Intermountain Healthcare Inc:企業の戦略的SWOT分析
    Intermountain Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • NextPharma Technologies Holding Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NextPharma Technologies Holding Ltd (NextPharma) is a contract development and manufacturing organization that provides pharmaceutical products and services. The company offers wide range of services such as pharmaceutical development, analytical services, clinical trials services, commercia …
  • Medical Research Council-製薬・医療分野:企業M&A・提携分析
    Summary Medical Research Council (MRC) is a human health research council that offers medical research programs. The council offers research across medical sciences services, universities and hospitals, centers and institutes. It provides data management, research platform, tools and facilities to g …
  • GVC Holdings PLC:戦略・SWOT・企業財務分析
    GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Danaher Corporation:企業の戦略・SWOT・財務情報
    Danaher Corporation - Strategy, SWOT and Corporate Finance Report Summary Danaher Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Transat A.T. Inc:企業の戦略・SWOT・財務情報
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Thomson Reuters Corporation:企業のM&A・事業提携・投資動向
    Thomson Reuters Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Thomson Reuters Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆